The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
MicroRNA-155—at the Critical Interface of Innate and Adaptive Immunity in Arthritis
Open accessAbstract
MicroRNAs (miRNAs) are small non-coding RNAs that fine-tune the cell response to a changing environment by modulating the cell transcriptome. miR-155 is a multifunctional miRNA enriched in cells of the immune system and is indispensable for the immune response. However, when deregulated, miR-155 contributes to the development of chronic inflammation, autoimmunity, cancer, and fibrosis. Herein, we review the evidence for the pathogenic role of miR-155 in driving aberrant activation of the immune system in rheumatoid arthritis, and its potential as a disease biomarker and therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626 · cited 1×
“At the cellular level, analysis of small RNA clone libraries by Landgraf and colleagues demonstrated that miR-155 is expressed in hematopoietic stem-progenitor cells and mature hematopoietic cells, including monocytes, granulocytes, B-cells, and T-cells (23).”
BackgroundDifferentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452
Identification of tissue-specific microRNAs from mouse
Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., & Tuschl, T. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00809-6 · Cited by 3,355
The molecular hallmarks of epigenetic control
Allis, C. D., & Jenuwein, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.59 · Cited by 2,809
Bushati, N., & Cohen, S. M. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123406 · Cited by 2,750
The Diverse Functions of MicroRNAs in Animal Development and Disease
Kloosterman, W. P., & Plasterk, R. H. A. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.09.009 · Cited by 2,082
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866 · cited 3×
“miR-155 is dispensable for DC differentiation but is an important regulator of DC activation; mice deficient in miR-155 have normal numbers of CD8a+cDCs, CD8a−cDCs, and pDCs (91); however, miR-155 is readily induced in mouse and human DCs following TLR stimulation (35, 92, 93).”
BackgroundRequirement of bic/microRNA-155 for Normal Immune Function
Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., et al. (2007) · Science · doi:10.1126/science.1139253 · Cited by 1,833 · cited 10×
“Th2 miR-155 was initially described as a negative regulator of Th2 commitment through the repression of its target c-Maf, which is an IL-4 promoter transactivator (98).”
BackgroundInfluentialImmunopathogenesis of Rheumatoid Arthritis
Firestein, G. S., & McInnes, I. B. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.006 · Cited by 1,301
Self-citationMicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development
O'Connell, R. M., Kahn, D., Gibson, W. S. J., Round, J. L., Scholz, R. L., Chaudhuri, A. A., Kahn, M. E., Rao, D. S., & Baltimore, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.009 · Cited by 889
Inositol phosphatase SHIP1 is a primary target of miR-155
O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., & Baltimore, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902636106 · Cited by 826
MicroRNAs as regulatory elements in immune system logic
Mehta, A., & Baltimore, D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.40 · Cited by 704
IsomiRs – the overlooked repertoire in the dynamic microRNAome
Neilsen, C. T., Goodall, G. J., & Bracken, C. P. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.07.005 · Cited by 499 · cited 1×
“However, the preferred guide strand can be changed by a single point mutation in the duplex (28), posttranscriptional modification of the duplex (29), and the type of proteins associated with Ago2 in the RISC complex (e.”
BackgroundMicroRNA-155 Modulates Treg and Th17 Cells Differentiation and Th17 Cell Function by Targeting SOCS1
Yao, R., Ma, Y.-L., Liang, W., Li, H.-H., Ma, Z.-J., Yu, X., & Liao, Y.-H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046082 · Cited by 309 · cited 1×
“miR-155 is upregulated in Th17 cells by STAT3, IRF-4 and RORγt and supports the development of Th17 by inhibiting its epigenetic target Jarid2, which itself is an epigenetic suppressor of Il22, Il10, Il9, and Atf3 (137), and by suppressing SOCS-1, thereby facilitating IL-6/STAT3 signaling (138).”
BackgroundSilencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis
Murugaiyan, G., Beynon, V., Mittal, A., Joller, N., & Weiner, H. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003952 · Cited by 289
An NF-κB-microRNA regulatory network tunes macrophage inflammatory responses
Mann, M., Mehta, A., Zhao, J. L., Lee, K., Marinov, G. K., Garcia-Flores, Y., Lu, L.-F., Rudensky, A. Y., & Baltimore, D. (2017) · Nature Communications · doi:10.1038/s41467-017-00972-z · Cited by 275
Regulation of miRNA strand selection: follow the leader?
Meijer, H. A., Smith, E. M., & Bushell, M. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140142 · Cited by 233
MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure
Triantafyllou, E., Pop, O. T., Possamai, L. A., Wilhelm, A., Liaskou, E., Singanayagam, A., Bernsmeier, C., Khamri, W., Petts, G., Dargue, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313615 · Cited by 226 · cited 1×
“, by tissue macrophages, upon activation of Tyrosine-protein kinase Mer (MerTK) by apoptotic inflammatory cells (42) and have broad anti-inflammatory”
Background
Research works printed but not linked: 143
- Baltimore, 2008, MicroRNAs: new regulators of immune cell development and function, Nat Immunol, 9, 839, 10.1038/ni.f.209 · DOI · Paper page
- He, 2004, MicroRNAs: small RNAs with a big role in gene regulation, Nat Rev Genet, 5, 522, 10.1038/nrg1415 · DOI
- Bartel, 2004, MicroRNAs, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
- Watts, 2017, MicroRNA29a treatment improves early tendon injury, Mol Ther, 25, 2415, 10.1016/j.ymthe.2017.07.015 · DOI
- Nagy, 2015, Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?, Arthritis Res Ther, 17, 181, 10.1186/s13075-015-0707-1 · DOI
- Ospelt, 2017, Epigenetics in the pathogenesis of RA, Semin Immunopathol, 39, 409, 10.1007/s00281-017-0621-5 · DOI
- Kim, 2009, Biogenesis of small RNAs in animals, Nat Rev Mol Cell Biol, 10, 126, 10.1038/nrm2632 · DOI · Paper page
- Brennecke, 2005, Principles of microRNA-target recognition, PLoS Biol, 3, e85, 10.1371/journal.pbio.0030085 · DOI · Paper page
- Doench, 2004, Specificity of microRNA target selection in translational repression, Genes Dev, 18, 504, 10.1101/gad.1184404 · DOI · Paper page
- Grimson, 2007, MicroRNA targeting specificity in mammals: determinants beyond seed pairing, Mol Cell, 27, 91, 10.1016/j.molcel.2007.06.017 · DOI · Paper page
- Tam, 1997, bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA, Mol Cell Biol, 17, 1490, 10.1128/MCB.17.3.1490 · DOI · Paper page
- Tam, 2001, Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA, Gene, 274, 157, 10.1016/S0378-1119(01)00612-6 · DOI · Paper page
- Zheng, 2010, MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts, Biochem Biophys Res Commun, 400, 483, 10.1016/j.bbrc.2010.08.067 · DOI
- Masaki, 2007, Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis, Biochem Biophys Res Commun, 364, 509, 10.1016/j.bbrc.2007.10.077 · DOI · Paper page
- Georgantas, 2007, CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control, Proc Natl Acad Sci U S A, 104, 2750, 10.1073/pnas.0610983104 · DOI · Paper page
- Griffiths-Jones, 2004, The microRNA registry, Nucleic Acids Res, 32, D109, 10.1093/nar/gkh023 · DOI · Paper page
- Ohanian, 2013, A heterozygous variant in the human cardiac miR-133 gene, MIR133A2, alters miRNA duplex processing and strand abundance, BMC Genet, 14, 18, 10.1186/1471-2156-14-18 · DOI · Paper page
- Lee, 2013, Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing, Nucleic Acids Res, 41, 6568, 10.1093/nar/gkt361 · DOI · Paper page
- Filipowicz, 2008, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?, Nat Rev Genet, 9, 102, 10.1038/nrg2290 · DOI
- Zhou, 2010, miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells, Blood, 116, 5885, 10.1182/blood-2010-04-280156 · DOI · Paper page
- Tarassishin, 2011, Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155, Glia, 59, 1911, 10.1002/glia.21233 · DOI
- Kurowska-Stolarska, 2017, The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis, J Allergy Clin Immunol, 139, 1946, 10.1016/j.jaci.2016.09.021 · DOI
- Bruning, 2011, MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia, Mol Cell Biol, 31, 4087, 10.1128/MCB.01276-10 · DOI · Paper page
- Quinn, 2014, The role of Ets2 transcription factor in the induction of microRNA-155 (miR-155) by lipopolysaccharide and its targeting by interleukin-10, J Biol Chem, 289, 4316, 10.1074/jbc.M113.522730 · DOI · Paper page
- Pottier, 2009, Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions, PLoS One, 4, e6718, 10.1371/journal.pone.0006718 · DOI · Paper page
- Kong, 2008, MicroRNA-155 is regulated by the transforming growth factor beta/smad pathway and contributes to epithelial cell plasticity by targeting RhoA, Mol Cell Biol, 28, 6773, 10.1128/MCB.00941-08 · DOI · Paper page
- Valeri, 2010, Modulation of mismatch repair and genomic stability by miR-155, Proc Natl Acad Sci U S A, 107, 6982, 10.1073/pnas.1002472107 · DOI · Paper page
- Rajasagi, 2017, Frontline science: aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology, J Leukoc Biol, 102, 1159, 10.1189/jlb.3HI1216-511RR · DOI
- Zheng, 2012, Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism, Free Radic Biol Med, 52, 1307, 10.1016/j.freeradbiomed.2012.01.031 · DOI
- Chinenov, 2014, Glucocorticoid receptor coordinates transcription factor-dominated regulatory network in macrophages, BMC Genomics, 15, 656, 10.1186/1471-2164-15-656 · DOI
- Bhattacharyya, 2013, Regulation of miR-155 biogenesis in cystic fibrosis lung epithelial cells: antagonistic role of two mRNA-destabilizing proteins, KSRP and TTP, Biochem Biophys Res Commun, 433, 484, 10.1016/j.bbrc.2013.03.025 · DOI
- Boldin, 2011, miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice, J Exp Med, 208, 1189, 10.1084/jem.20101823 · DOI · Paper page
- Elton, 2013, Regulation of the MIR155 host gene in physiological and pathological processes, Gene, 532, 1, 10.1016/j.gene.2012.12.009 · DOI · Paper page
- Murray, 2014, Macrophage activation and polarization: nomenclature and experimental guidelines, Immunity, 41, 14, 10.1016/j.immuni.2014.06.008 · DOI · Paper page
- Misharin, 2014, Nonclassical Ly6C(-) monocytes drive the development of inflammatory arthritis in mice, Cell Rep, 9, 591, 10.1016/j.celrep.2014.09.032 · DOI · Paper page
- Self-Fordham, 2017, MicroRNA: dynamic regulators of macrophage polarization and plasticity, Front Immunol, 8, 1062, 10.3389/fimmu.2017.01062 · DOI
- An, 2005, Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism, Blood, 105, 4685, 10.1182/blood-2005-01-0191 · DOI · Paper page
- Wang, 2010, Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1, J Immunol, 185, 6226, 10.4049/jimmunol.1000491 · DOI · Paper page
- Nazari-Jahantigh, 2012, MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages, J Clin Invest, 122, 4190, 10.1172/JCI61716 · DOI · Paper page
- Kurowska-Stolarska, 2011, MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis, Proc Natl Acad Sci U S A, 108, 11193, 10.1073/pnas.1019536108 · DOI · Paper page
- Jing, 2015, CRISPR/CAS9-mediated genome editing of miRNA-155 inhibits proinflammatory cytokine production by RAW264.7 cells, Biomed Res Int, 2015, 326042, 10.1155/2015/326042 · DOI
- He, 2009, MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta, Cell Mol Immunol, 6, 343, 10.1038/cmi.2009.45 · DOI · Paper page
- Kim, 2017, The transcription factor MafB promotes anti-inflammatory M2 polarization and cholesterol efflux in macrophages, Sci Rep, 7, 7591, 10.1038/s41598-017-07381-8 · DOI · Paper page
- Martinez-Nunez, 2011, The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1), J Biol Chem, 286, 1786, 10.1074/jbc.M110.169367 · DOI · Paper page
- Wahl, 1993, Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta, J Exp Med, 177, 225, 10.1084/jem.177.1.225 · DOI
- Louafi, 2010, MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}, J Biol Chem, 285, 41328, 10.1074/jbc.M110.146852 · DOI · Paper page
- Bluml, 2011, Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice, Arthritis Rheum, 63, 1281, 10.1002/art.30281 · DOI · Paper page
- Elmesmari, 2016, MicroRNA-155 regulates monocyte chemokine and chemokine receptor expression in rheumatoid arthritis, Rheumatology (Oxford), 55, 2056, 10.1093/rheumatology/kew272 · DOI
- Stanczyk, 2008, Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis Rheum, 58, 1001, 10.1002/art.23386 · DOI · Paper page
- Tian, 2014, Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis, Cardiovasc Res, 103, 100, 10.1093/cvr/cvu070 · DOI
- Herenius, 2011, Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab, Ann Rheum Dis, 70, 1160, 10.1136/ard.2010.141549 · DOI
- Asquith, 2015, Targeting cell migration in rheumatoid arthritis, Curr Opin Rheumatol, 27, 204, 10.1097/BOR.0000000000000150 · DOI
- Yoon, 2014, Functional phenotype of synovial monocytes modulating inflammatory T-cell responses in rheumatoid arthritis (RA), PLoS One, 9, e109775, 10.1371/journal.pone.0109775 · DOI
- Walter, 2013, Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells, Arthritis Rheum, 65, 627, 10.1002/art.37832 · DOI
- Evans, 2009, In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses, Proc Natl Acad Sci U S A, 106, 6232, 10.1073/pnas.0808144106 · DOI · Paper page
- Firestein, 1987, Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. i. a cytofluorographic study of monocyte differentiation antigens and class ii antigens and their regulation by γgm-interferon, Arthritis Rheum, 30, 857, 10.1002/art.1780300803 · doi:10.1002/art.1780300803
- Highton, 2008, Changes in the phenotype of monocytes/macrophages and expression of cytokine mRNA in peripheral blood and synovial fluid of patients with rheumatoid arthritis, Clin Exp Immunol, 102, 541, 10.1111/j.1365-2249.1995.tb03850.x · doi:10.1111/j.1365-2249.1995.tb03850.x
- De Rycke, 2005, Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis, J Pathol, 206, 17, 10.1002/path.1758 · DOI
- Chu, 1991, Localization of tumor-necrosis-factor-alpha in synovial tissues and at the cartilage pannus junction in patients with rheumatoid-arthritis, Arthritis Rheum, 34, 1125, 10.1002/art.1780340908 · DOI · Paper page
- Danks, 2002, Synovial macrophage-osteoclast differentiation in inflammatory arthritis, Ann Rheum Dis, 61, 916, 10.1136/ard.61.10.916 · DOI
- Adamopoulos, 2006, Synovial fluid macrophages are capable of osteoclast formation and resorption, J Pathol, 208, 35, 10.1002/path.1891 · DOI
- Syed, 2015, miR155 expression is increased by inflammation and modulates the expression of CD11a in monocytes, FASEB J, 29, 634.6, 10.1096/fasebj.29.1_supplement.634.6 · DOI
- Perlman, 2001, Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1?-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis, Arthritis Rheum, 44, 21, 10.1002/1529-0131(200101)44:1<21::AID-ANR4>3.0.CO;2-8 · doi:10.1002/1529-0131(200101)44:1<21::aid-anr4>3.0.co;2-8
- Liu, 2006, Regulation of Mcl-1 expression in rheumatoid arthritis synovial macrophages, Arthritis Rheum, 54, 3174, 10.1002/art.22132 · DOI
- Meusch, 2009, Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1beta production and deficient apoptosis of rheumatoid arthritis monocytes, Arthritis Rheum, 60, 2612, 10.1002/art.24778 · DOI
- Srivastava, 2010, Monocytes are resistant to apoptosis in systemic juvenile idiopathic arthritis, Clin Immunol, 136, 257, 10.1016/j.clim.2010.04.003 · DOI
- Rajasekhar, 2017, MicroRNA-155 contributes to enhanced resistance to apoptosis in monocytes from patients with rheumatoid arthritis, J Autoimmun, 79, 53, 10.1016/j.jaut.2017.01.002 · DOI
- Wang, 2017, Macrophage-derived mir-155-containing exosomes suppress fibroblast proliferation and promote fibroblast inflammation during cardiac injury, Mol Ther, 25, 192, 10.1016/j.ymthe.2016.09.001 · DOI · Paper page
- Steinman, 2007, Taking dendritic cells into medicine, Nature, 449, 419, 10.1038/nature06175 · DOI · Paper page
- Banchereau, 1998, Dendritic cells and the control of immunity, Nature, 392, 245, 10.1038/32588 · DOI · Paper page
- Zhou, 2017, The development and function of dendritic cell populations and their regulation by miRNAs, Protein Cell, 8, 501, 10.1007/s13238-017-0398-2 · DOI
- Reis e Sousa, 2006, Dendritic cells in a mature age, Nat Rev Immunol, 6, 476, 10.1038/nri1845 · DOI · Paper page
- Kawai, 2006, TLR signaling, Cell Death Differ, 13, 816, 10.1038/sj.cdd.4401850 · DOI · Paper page
- Dunand-Sauthier, 2011, Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function, Blood, 117, 4490, 10.1182/blood-2010-09-308064 · DOI
- Ceppi, 2009, MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells, Proc Natl Acad Sci U S A, 106, 2735, 10.1073/pnas.0811073106 · DOI · Paper page
- Martinez-Nunez, 2009, MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN), J Biol Chem, 284, 16334, 10.1074/jbc.M109.011601 · DOI · Paper page
- Shen, 2008, Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation, J Immunol, 181, 1849, 10.4049/jimmunol.181.3.1849 · DOI · Paper page
- Dudziak, 2007, Differential antigen processing by dendritic cell subsets in vivo, Science, 315, 107, 10.1126/science.1136080 · DOI · Paper page
- Lind, 2015, miR-155 upregulation in dendritic cells is sufficient to break tolerance in vivo by negatively regulating SHIP1, J Immunol, 195, 4632, 10.4049/jimmunol.1302941 · DOI
- Lu, 2011, miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1, Blood, 117, 4293, 10.1182/blood-2010-12-322503 · DOI · Paper page
- Jongbloed, 2006, Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis, Arthritis Res Ther, 8, R15, 10.1186/ar1864 · DOI · Paper page
- Kurowska-Stolarska, 2017, MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis, Nat Commun, 8, 15877, 10.1038/ncomms15877 · DOI
- Moret, 2015, The efficacy of abatacept in reducing synovial T cell activation by CD1c myeloid dendritic cells is overruled by the stimulatory effects of T cell-activating cytokines, Arthritis Rheumatol, 67, 637, 10.1002/art.38982 · DOI
- Moret, 2013, Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity, Arthritis Res Ther, 15, R155, 10.1186/ar4338 · DOI
- Thai, 2007, Regulation of the germinal center response by microRNA-155, Science, 316, 604, 10.1126/science.1141229 · DOI · Paper page
- Musilova, 2015, MicroRNAs in B-cell lymphomas: how a complex biology gets more complex, Leukemia, 29, 1004, 10.1038/leu.2014.351 · DOI · Paper page
- Costinean, 2009, Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice, Blood, 114, 1374, 10.1182/blood-2009-05-220814 · DOI · Paper page
- Costinean, 2006, Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice, Proc Natl Acad Sci U S A, 103, 7024, 10.1073/pnas.0602266103 · DOI · Paper page
- Sandhu, 2012, miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the E mu-miR-155 transgenic mouse model, Proc Natl Acad Sci U S A, 109, 20047, 10.1073/pnas.1213764109 · DOI
- Jiang, 2014, MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-beta1/SMAD5 signaling module, Blood, 123, 86, 10.1182/blood-2013-07-515254 · DOI
- Babar, 2012, Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma, Proc Natl Acad Sci U S A, 109, E1695, 10.1073/pnas.1201516109 · DOI · Paper page
- Klein, 2008, Germinal centres: role in B-cell physiology and malignancy, Nat Rev Immunol, 8, 22, 10.1038/nri2217 · DOI · Paper page
- Cui, 2014, MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia, Blood, 124, 546, 10.1182/blood-2014-03-559690 · DOI · Paper page
- Vigorito, 2007, microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells, Immunity, 27, 847, 10.1016/j.immuni.2007.10.009 · DOI · Paper page
- Thai, 2013, Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse, Proc Natl Acad Sci U S A, 110, 20194, 10.1073/pnas.1317632110 · DOI
- Lu, 2014, The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation, J Exp Med, 211, 2183, 10.1084/jem.20140338 · DOI
- Liu, 2015, TLR9-induced miR-155 and Ets-1 decrease expression of CD1d on B cells in SLE, Eur J Immunol, 45, 1934, 10.1002/eji.201445286 · DOI
- van de Stadt, 2011, Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis, Arthritis Rheum, 63, 3226, 10.1002/art.30537 · DOI · Paper page
- Ferraccioli, 2012, Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis, PLoS One, 7, e40362, 10.1371/journal.pone.0040362 · DOI
- Fekete, 2007, Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses, J Autoimmun, 29, 154, 10.1016/j.jaut.2007.07.002 · DOI
- Souto-Carneiro, 2009, Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor, Arthritis Res Ther, 11, R84, 10.1186/ar2718 · DOI
- Fedele, 2014, Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis, BMC Immunol, 15, 28, 10.1186/s12865-014-0028-1 · doi:10.1186/s12865-014-0028-1
- Alivernini, 2016, MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis, Nat Commun, 7, 12970, 10.1038/ncomms12970 · DOI
- Mahmood, 2015, CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis, Arthritis Res Ther, 17, 61, 10.1186/s13075-015-0580-y · DOI
- Rodriguez-Bayona, 2010, Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients, Arthritis Res Ther, 12, R108, 10.1186/ar3042 · DOI
- Tangye, 2009, Memory B cells: effectors of long-lived immune responses, Eur J Immunol, 39, 2065, 10.1002/eji.200939531 · DOI · Paper page
- Orr, 2017, Synovial immunophenotype and anti-citrullinated peptide antibodies in rheumatoid arthritis patients: relationship to treatment response and radiologic prognosis, Arthritis Rheumatol, 69, 2114, 10.1002/art.40218 · DOI
- Pitzalis, 2013, New learnings on the pathophysiology of RA from synovial biopsies, Curr Opin Rheumatol, 25, 334, 10.1097/BOR.0b013e32835fd8eb · DOI · Paper page
- Reiner, 2007, Development in motion: helper T cells at work, Cell, 129, 33, 10.1016/j.cell.2007.03.019 · DOI · Paper page
- Cobb, 2005, T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer, J Exp Med, 201, 1367, 10.1084/jem.20050572 · DOI · Paper page
- Muljo, 2005, Aberrant T cell differentiation in the absence of Dicer, J Exp Med, 202, 261, 10.1084/jem.20050678 · DOI · Paper page
- Banerjee, 2010, Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells, Eur J Immunol, 40, 225, 10.1002/eji.200939381 · DOI · Paper page
- Eis, 2005, Accumulation of miR-155 and BIC RNA in human B cell lymphomas, Proc Natl Acad Sci U S A, 102, 3627, 10.1073/pnas.0500613102 · DOI · Paper page
- Haasch, 2002, T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC, Cell Immunol, 217, 78, 10.1016/S0008-8749(02)00506-3 · DOI · Paper page
- van den Berg, 2003, High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma, Genes Chromosomes Cancer, 37, 20, 10.1002/gcc.10186 · DOI · Paper page
- Malmhall, 2014, MicroRNA-155 is essential for T(H)2-mediated allergen-induced eosinophilic inflammation in the lung, J Allergy Clin Immunol, 133, 1429, 10.1016/j.jaci.2013.11.008 · DOI · Paper page
- Okoye, 2014, Transcriptomics identified a critical role for Th2 cell-intrinsic miR-155 in mediating allergy and antihelminth immunity, Proc Natl Acad Sci U S A, 111, E3081, 10.1073/pnas.1406322111 · DOI
- Escobar, 2014, miR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression, Immunity, 40, 865, 10.1016/j.immuni.2014.03.014 · DOI · Paper page
- Hu, 2013, MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression, J Immunol, 190, 5972, 10.4049/jimmunol.1300351 · DOI
- Hu, 2014, miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation, Immunity, 41, 605, 10.1016/j.immuni.2014.09.015 · DOI · Paper page
- Kohlhaas, 2009, Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells, J Immunol, 182, 2578, 10.4049/jimmunol.0803162 · DOI · Paper page
- Lu, 2009, Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein, Immunity, 30, 80, 10.1016/j.immuni.2008.11.010 · DOI · Paper page
- Asirvatham, 2008, MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components, Mol Immunol, 45, 1995, 10.1016/j.molimm.2007.10.035 · DOI · Paper page
- Sonkoly, 2010, MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4, J Allergy ClinImmunol, 126, 581, 10.1016/j.jaci.2010.05.045 · DOI · Paper page
- Zhang, 2010, Dicer controls CD8+ T-cell activation, migration, and survival, Proc Natl Acad Sci U S A, 107, 21629, 10.1073/pnas.1016299107 · DOI
- Gracias, 2013, The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling, Nat Immunol, 14, 593, 10.1038/ni.2576 · DOI · Paper page
- Smigielska-Czepiel, 2014, Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs, Genes Immun, 15, 115, 10.1038/gene.2013.69 · DOI
- Dejaco, 2010, Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica, Rheumatol Int, 30, 297, 10.1007/s00296-009-0949-9 · DOI
- Mottonen, 2005, CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis, Clin Exp Immunol, 140, 360, 10.1111/j.1365-2249.2005.02754.x · DOI · Paper page
- Raghavan, 2009, FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment, Ann Rheum Dis, 68, 1908, 10.1136/ard.2008.100768 · DOI
- van Amelsfort, 2004, CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid, Arthritis Rheum, 50, 2775, 10.1002/art.20499 · DOI · Paper page
- Valencia, 2006, TNF downmodulates the function of human CD4+CD25hi T-regulatory cells, Blood, 108, 253, 10.1182/blood-2005-11-4567 · DOI · Paper page
- Wehrens, 2013, T cells out of control – impaired immune regulation in the inflamed joint, Nat Rev Rheumatol, 9, 34, 10.1038/nrrheum.2012.149 · DOI
- Zhou, 2015, Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis, Ann Rheum Dis, 74, 1265, 10.1136/annrheumdis-2013-204377 · DOI · Paper page
- Garcia-Rodriguez, 2017, Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity, J Eur Acad Dermatol Venereol, 31, 312, 10.1111/jdv.13861 · DOI
- Jopling, 2005, Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA, Science, 309, 1577, 10.1126/science.1113329 · DOI · Paper page
- Misso, 2014, Mir-34: a new weapon against cancer?, Mol Ther Nucleic Acids, 3, e194, 10.1038/mtna.2014.47 · DOI · Paper page
- Millar, 2015, MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease, Nat Commun, 6, 6774, 10.1038/ncomms7774 · DOI · Paper page
- Morton, 2015, Neutralisation of miR-155 ameliorates collagen-induced arthritis, Ann Rheum Dis, 74, 84, 10.1136/annrheumdis-2015-207259.194 · doi:10.1136/annrheumdis-2015-207259.194
- Miller, 2013, MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice, PLoS One, 8, e72324, 10.1371/journal.pone.0072324 · DOI
- Cheng, 2015, MicroRNA silencing for cancer therapy targeted to the tumour microenvironment, Nature, 518, 107, 10.1038/nature13905 · DOI · Paper page
- Ng, 2010, Synovial tissue hypoxia and inflammation in vivo, Ann Rheum Dis, 69, 1389, 10.1136/ard.2009.119776 · DOI · Paper page
- Cross, 2017, AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis, Br J Pharmacol, 174, 3045, 10.1111/bph.13934 · DOI
Cited by
Macrophages: The Good, the Bad, and the Gluttony
Ross, E. A., Devitt, A., & Johnson, J. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708186 · Cited by 431
Saleh, H. A., Yousef, M. H., & Abdelnaser, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.606069 · Cited by 255
A Mechanism for microRNA Arm Switching Regulated by Uridylation
Kim, H., Kim, J., Yu, S., Lee, Y.-Y., Park, J., Choi, R. J., Yoon, S.-J., Kang, S.-G., & Kim, V. N. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.030 · Cited by 99
MicroRNAs: a symphony orchestrating evolution and disease dynamics
Quah, S., Subramanian, G., Tan, J. S. L., Utami, K. H., & Sampath, P. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.07.004 · Cited by 31
Corbet, M., Pineda, M. A., Yang, K., Tarafdar, A., McGrath, S., Nakagawa, R., Lumb, F. E., Suckling, C. J., Harnett, W., & Harnett, M. M. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1010069 · Cited by 22
Metadata
- Authors
- Alivernini, S., Gremese, E., McSharry, C., Tolusso, B., Ferraccioli, G., McInnes, I. B., & Kurowska-Stolarska, M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-01-05
- Volume
- 8
- Pages
- 1932-1932
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2782197585
- Cited by
- 228
- References
- 22
- FWCI
- 20.18
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Arthritis Research UK (RACE20298)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.